Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer.

Trial Profile

Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Dec 2017

At a glance

  • Drugs Goserelin (Primary) ; Cyclophosphamide
  • Indications Primary ovarian insufficiency
  • Focus Therapeutic Use
  • Acronyms POEMS
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 09 Dec 2017 Results of final analysis of the study (five-year follow up) , presented at the 40th Annual San Antonio Breast Cancer Symposium.
    • 28 Oct 2016 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top